Avandia Increases Risk of Heart Failure and Death
Attorney
(866) 735-1102 Ext 308
Have you, a loved one, or friend taken Avandia and been injured? Avandia has been associated with heart failure, and in some cases, death. Avandia, which is manufactured by GlaxoSmithKline, is an oral diabetes medicine that helps control blood sugar levels by making the cells of the body more sensitive to the action of insulin. This drug is for Type 2 Diabetes only.
Avandia can cause or exacerbate congestive heart failure in some patients. Studies have shown that this drug is associated with an increased risk of myocardial ischemic events such as angina or myocardial infarction. During a six-year study, 6.9 percent of patients on Avandia died or were hospitalized for a heart attack or heart failure. In fact, patients taking Avandia are more likely to develop heart failure or die than those taking rival drugs, such as Actos.
Researchers of the review remark that given the evidence of harm with Avandia and the lack of benefit beyond what is seen with rival drugs, it’s reasonable to question whether continued use is justified. Although the drug comes with a warning on it’s label, Alan Ripka, Esq., maintains that those taking Avandia should be screened, warned and monitored for all the potential side effects. Those injured as a result of taking Avandia may be entitled to compensation for their pain, suffering, medical bills and lost income.
If you, a friend, or loved one takes Avandia, and think you have been harmed as a result, please contact our law office. The professional team of lawyers at Napoli Bern Ripka law firm can evaluate your situation and determine the next steps to gain justice for you and your family. Napoli Bern Ripka, LLP has fought against large companies in other matters and will fight for you if we believe you have a potential case for medical malpractice, products liability, personal injury, and medical malpractice is prepared to go to court and have a trial if necessary. Please contact our office and ask for Alan Ripka, one of our partners. Please specifically mention that you read the blog when contacting our office.